Lerman C - Search Results

1

Smoking cessation treatment: pharmacogenetic assessment.

Munafò MR, Lerman C, Niaura R, Shields AE, Swan GE. Munafò MR, et al. Among authors: lerman c. Curr Opin Mol Ther. 2005 Jun;7(3):202-8. Curr Opin Mol Ther. 2005. PMID: 15977416 Review.

2

Attention-Deficit Hyperactivity Disorder (ADHD) symptoms and smoking patterns among participants in a smoking-cessation program.

Lerman C, Audrain J, Tercyak K, Hawk LW Jr, Bush A, Crystal-Mansour S, Rose C, Niaura R, Epstein LH. Lerman C, et al. Nicotine Tob Res. 2001 Nov;3(4):353-9. doi: 10.1080/14622200110072156. Nicotine Tob Res. 2001. PMID: 11694203 Clinical Trial.

3

Non-replication of genetic association studies: is DAT all, folks?

Lerman C, Swan GE. Lerman C, et al. Nicotine Tob Res. 2002 Aug;4(3):247-9. doi: 10.1080/14622200210141220. Nicotine Tob Res. 2002. PMID: 12215232 No abstract available.

4

Applying genetic approaches to the treatment of nicotine dependence.

Lerman C, Niaura R. Lerman C, et al. Oncogene. 2002 Oct 21;21(48):7412-20. doi: 10.1038/sj.onc.1205801. Oncogene. 2002. PMID: 12379882 Review.

5

Which adolescents are most receptive to tobacco industry marketing? implications for counter-advertising campaigns.

Audrain-McGovern J, Tercyak KP, Shields AE, Bush A, Espinel CF, Lerman C. Audrain-McGovern J, et al. Among authors: lerman c. Health Commun. 2003;15(4):499-513. doi: 10.1207/S15327027HC1504_07. Health Commun. 2003. PMID: 14527869

6

Intergenerational transmission of tobacco use and dependence: a transdisciplinary perspective.

Shenassa ED, McCaffery JM, Swan GE, Khroyan TV, Shakib S, Lerman C, Lyons M, Mouttapa M, Niaura RS, Buka SL, Leslie F, Santangelo SL. Shenassa ED, et al. Among authors: lerman c. Nicotine Tob Res. 2003 Dec;5 Suppl 1:S55-69. doi: 10.1080/14622200310001625500. Nicotine Tob Res. 2003. PMID: 14668087 Review.

7

Transdisciplinary science applied to the evaluation of treatments for tobacco use.

Baker TB, Hatsukami DK, Lerman C, O'Malley SS, Shields AE, Fiore MC. Baker TB, et al. Among authors: lerman c. Nicotine Tob Res. 2003 Dec;5 Suppl 1:S89-99. doi: 10.1080/14622200310001625564. Nicotine Tob Res. 2003. PMID: 14668089 Review.

8

Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling.

Collins BN, Wileyto EP, Patterson F, Rukstalis M, Audrain-McGovern J, Kaufmann V, Pinto A, Hawk L, Niaura R, Epstein LH, Lerman C. Collins BN, et al. Among authors: lerman c. Nicotine Tob Res. 2004 Feb;6(1):27-37. doi: 10.1080/14622200310001656830. Nicotine Tob Res. 2004. PMID: 14982685 Clinical Trial.

9

Genetic testing for cancer susceptibility: the promise and the pitfalls.

Lerman C, Shields AE. Lerman C, et al. Nat Rev Cancer. 2004 Mar;4(3):235-41. doi: 10.1038/nrc1301. Nat Rev Cancer. 2004. PMID: 14993905 Review. No abstract available.

10

Ethical issues in conducting behavioral genetics research: the case of smoking prevention trials among adolescents.

Wilfond BS, Geller G, Lerman C, Audrain-McGovern J, Shields AE. Wilfond BS, et al. Among authors: lerman c. J Health Care Law Policy. 2002;6(1):73-88. J Health Care Law Policy. 2002. PMID: 15017952 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

433 results

Search Page

Filters